Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immucor -- Ignore unavailable to you. Want to Upgrade?

To: Jodi Segal-Lankry who wrote (30)	2/19/1998 10:42:00 PM
From: Thomas Kirwin	Read Replies (1) \| Respond to of 422

"It's Not A Question of If, It's When the ABS2000 Is Approved" Jodi, These powerful words were recently stated by an Immucor employee during a phone conversation. They truly believe in this gizmo! I invested in BLUD some two years ago, made some chump change, lost patience and have returned to reap the Holy Grail. My gut tells me that it is just about time the device receives the a-ok from the FDA. Two years is a long time for a non-invasive testing instrument to be approved. Sure, I understand that ABS2000 relies on reagents to facilitate the matching process and the FDA wants to fully understand the pros and cons, but two years for approval is ridiculous. Don't forget that the ABS2000 is already being utilized in Canada and Europe. I believe that 25 are up and running without any problem. The ABS2000 and reagents (AKA razor and blades) economic/profit model bode well for Immucor once approval is granted. They will have a lock on the blood instrument industry. The future sales opportunities will be endless. I hope that this long winded response answers your query. Just in case let me make it perfectly clear that I personally expect approval very soon. Regards, Tom P.S. The above is my opinion. Please perform your own do-diligence before investing.

To: Jodi Segal-Lankry who wrote (30)	9/13/1998 8:13:00 PM
From: Thomas Kirwin	Respond to of 422

Insider Buying Analysis II Hello, Just a quick update to my previous post on Insider Buying. Lets not forget that Mr. Dennis Smith, Director, recently purchased 5,000 shares on 8/25/98 increasing his holdings to 45,312 shares. He also has 10,000 options issued upon his election as an Immucor director at the stock's then current fair market value on or about April 17, 1998. I've already indicated the significance of Mr. Steven Ramsey's purchases in reply #58 dated Sunday, May 3 1998 11:06AM ET. Simply follow the link below to review: Message 4303164 Regards, Tom